We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+0.52%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$15.3B
AUM Growth
+$933M
(+6.5%)
Cap. Flow
+$1.09B
Cap. Flow
% of AUM
7.1%
Top 10 Holdings %
Top 10 Hldgs %
20.85%
Holding
1,816
New
17
Increased
573
Reduced
1,124
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$111M |
| 2 |
Amazon
AMZN
|
+$95.9M |
| 3 |
Microsoft
MSFT
|
+$91.8M |
| 4 |
Roper Technologies
ROP
|
+$69.8M |
| 5 |
PX
Praxair Inc
PX
|
+$68.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brown-Forman Class B
BF.B
|
+$28.4M |
| 2 |
Becton Dickinson
BDX
|
+$28M |
| 3 |
W.W. Grainger
GWW
|
+$20.5M |
| 4 |
Lowe's Companies
LOW
|
+$15M |
| 5 |
Target
TGT
|
+$10.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.5% |
| 2 | Financials | 13.66% |
| 3 | Healthcare | 12.92% |
| 4 | Consumer Discretionary | 10.42% |
| 5 | Industrials | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Innoviva
INVA
$1.58B
| $980K | 0.01% |
58,810
-12,749
| -18% | -$197K |
|
827
Targa Resources
TRGP
$60.4B
| $977K | 0.01% |
22,213
+6,424
| +41% | +$306K |
|
828
Ziff Davis
ZD
$1.9B
| $977K | 0.01% |
14,237
-841
| -6% | -$56.9K |
|
|
AIMT
829
DELISTED
Aimmune Therapeutics
AIMT
| $977K | 0.01% |
30,709
-1,917
| -6% | -$67.5K |
|
830
Tyler Technologies
TYL
$12.2B
| $975K | 0.01% |
4,621
+138
| +3% | +$27.6K |
|
831
CRISPR Therapeutics
CRSP
$4.58B
| $973K | 0.01% |
21,277
-823
| -4% | -$34K |
|
|
SPPI
832
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $973K | 0.01% |
60,456
-9,428
| -13% | -$187K |
|
|
MASI
833
DELISTED
Masimo
MASI
| $964K | 0.01% |
10,956
-1,090
| -9% | -$95K |
|
834
Viasat
VSAT
$9.79B
| $964K | 0.01% |
14,666
-192
| -1% | -$14K |
|
|
CADE
835
DELISTED
Cadence Bank
CADE
| $962K | 0.01% |
30,260
-1,870
| -6% | -$61.5K |
|
|
ARNA
836
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $959K | 0.01% |
24,272
-2,717
| -10% | -$106K |
|
837
Essent Group
ESNT
$6.06B
| $956K | 0.01% |
22,454
-1,674
| -7% | -$75.9K |
|
838
ProShares Inflation Expectations ETF
RINF
$18.5M
| $956K | 0.01% |
33,782
+23,986
| +245% | +$684K |
|
839
Apple Hospitality REIT
APLE
$3.96B
| $955K | 0.01% |
54,336
-1,073
| -2% | -$19.7K |
|
|
ISBC
840
DELISTED
Investors Bancorp, Inc.
ISBC
| $955K | 0.01% |
69,996
-5,741
| -8% | -$79.6K |
|
|
RDUS
841
DELISTED
Radius Health, Inc.
RDUS
| $954K | 0.01% |
26,551
-4,247
| -14% | -$153K |
|
|
WCG
842
DELISTED
Wellcare Health Plans, Inc.
WCG
| $954K | 0.01% |
4,925
-172
| -3% | -$34.4K |
|
|
HOUS
843
DELISTED
Anywhere Real Estate
HOUS
| $952K | 0.01% |
34,892
-768
| -2% | -$20.2K |
|
|
HBI
844
DELISTED
Hanesbrands
HBI
| $949K | 0.01% |
51,538
+808
| +2% | +$16.7K |
|
|
SGMO
845
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $946K | 0.01% |
49,797
-8,187
| -14% | -$175K |
|
846
Repligen
RGEN
$7.44B
| $945K | 0.01% |
26,117
-4,069
| -13% | -$143K |
|
847
Maximus
MMS
$3.14B
| $944K | 0.01% |
14,142
-1,491
| -10% | -$101K |
|
|
MDSO
848
DELISTED
Medidata Solutions, Inc.
MDSO
| $940K | 0.01% |
14,972
-902
| -6% | -$60K |
|
849
Kemper
KMPR
$1.7B
| $933K | 0.01% |
16,369
-910
| -5% | -$55.9K |
|
850
First Financial Bankshares
FFIN
$4.97B
| $930K | 0.01% |
40,176
-1,986
| -5% | -$46.6K |
|
Similar funds
ProShare Advisors's Q1 2018 Portfolio in Review
As of Q1 2018, ProShare Advisors held 1,816 positions worth $15.3B, up 6.5% from $14.4B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
ProShare Advisors deployed $1.09B of net new capital in Q1 2018, opening 17 new positions and adding to 573 existing holdings. Its largest new stake was CoStar Group: 93,260 shares worth $3.38M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Brown-Forman Class B, an estimated $28.4M trimmed.
- ProShare Advisors's largest Q1 2018 buy was CoStar Group: 93,260 shares worth $3.38M.
- ProShare Advisors added most to Apple in Q1 2018, an estimated $111M increase.
- ProShare Advisors's biggest Q1 2018 reduction was Brown-Forman Class B, cutting an estimated $28.4M.
- ProShare Advisors fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $3.8M.
- ProShare Advisors's ten largest holdings make up 21% of its $15.3B portfolio in Q1 2018.
- ProShare Advisors opened 17 new positions and closed 101 in Q1 2018.
- ProShare Advisors's portfolio value rose 6.5% quarter-over-quarter to $15.3B.
Based on ProShare Advisors's 13F filing for Q1 2018, filed 14 May 2018.